Natreon to Present Initial Positive Results on Two Clinical Trials on PrimaVie® and Sensoril® at the ISSN Sports Nutrition Conference

Share Article

Innovative nutritional ingredient company Natreon will present posters on two new clinical studies designed to measure the benefits of supplementation with PrimaVie® and Sensoril® in sports performance.

Natreon, Inc., an innovative ingredient supplier known for its patented ingredients derived from nature, will share results from their latest clinical studies at the International Society of Sports Nutrition (ISSN) 15th Annual Conference and Expo, which is held from June 7 to 9, 2018 in Clearwater Beach, FL. Dr. Tim N. Ziegenfuss, CEO from The Center for Applied Health Sciences (CAHS) will present preliminary data on Natreon’s patented Sensoril (ashwagandha) ingredient titled “Effect of Sensoril® on Strength Training Adaptations, Body Composition, Muscular Performance and Recovery: the STAR Trial.”

This randomized, double-blind, parallel-group, placebo controlled clinical trial studied the effects of different doses of Sensoril® on the sports performance of 66 healthy and recreationally active male participants aged of 18 to 45. Initial results found significant improvements in the Sensoril® group for numerous sports performance measures, including 1-repetition measure squat, peak power bench, peak power squat and repetitions-to-failure on the bench press. It also showed an improvement in subjects’ perceived recovery score.

Joshua Keller from The Department of Nutrition and Health Sciences at University of Nebraska Lincoln will present preliminary data on Natreon’s biome optimized PrimaVie® ingredient titled “The Effects of Shilajit Supplement on Fatigue-Induced Decreases in Muscular Strength.”

This double-blind, placebo-controlled, parallel-designed trial studied the effects of two doses of PrimaVie® compared to a placebo on fatigue-induced percent decline in maximal voluntary isometric contraction (MVIC) in 30 recreationally trained men. The results showed that the PrimaVie® group helped maintain more muscular strength. Other dependent variables are still being analyzed and more evaluation is to come. This study will be submitted for publication once all analysis is complete.

ISSN conference participants can learn more about these clinical studies during the poster presentations from 12 to 2 pm on Saturday, June 9th. Learn more about Natreon’s innovative ingredients at http://www.natreonone.com.

About Sensoril®
Sensoril® is a patented Ashwagandha extract supported by 11 clinical studies designed to enhance adaptogenic health benefits. This Ayurvedic botanical has been revered for thousands of years for its ability to balance, energize, and revitalize. Sensoril® contains the highest level of bioactives on the market (>10% withanolide glycosides) making it a powerful adaptogen which helps to enhance mental stamina and reduce fatigue for a more balanced body and mind.

About PrimaVie®
PrimaVie® is a Biome Optimized Shilajit™ backed by 8 clinical studies to promote energy, endurance, and healthy aging. Considered the greatest rasayana and most potent ingredient in Ayurveda, Shilajit’s use goes back to 3,000 B.C. PrimaVie® is sourced from distinct biological ecosystems (biomes) and processed using Green Chemistry Principles (water extraction) to achieve an optimal nutrient profile. PrimaVie® is the highest bioactive Shilajit on the market. It consists of Fulvic acid, Urolithins (DBPs), and over 40 micro-minerals, which help promote sports nutrition, male health and healthy aging benefits.

About Natreon, Inc.:
Natreon, Inc. is proud to lead the industry in patented, scientifically validated Ayurvedic botanicals that contain optimal levels of bioactives. Since 1998, this innovative New Jersey-based company has been bringing the public exciting natural ingredients through partners in the food and beverage, dietary supplement, medical food and personal care industries. Natreon is focused on developing breakthrough botanical products that are backed by science. It works with a state-of-the-art research and development facility in India and performs high-quality clinical and safety studies to ensure the standardization and effectiveness of its products. Learn more about Natreon’s products and research at http://www.natreoninc.com.

For further information please contact:
Dr. Sanni Raju, CEO/Chairman or Bruce Brown, President
2-D Janine Place
New Brunswick, NJ 08901
732-296-1080

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sean Rohan
Natreon, Inc.
+1 7322961080 Ext: 20
Email >
Visit website